REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 66 filers reported holding REVANCE THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,978,900 | -54.7% | 870,000 | 0.0% | 0.22% | -53.2% |
| Q2 2023 | $22,019,700 | +50.7% | 870,000 | -3.3% | 0.47% | +0.9% |
| Q4 2019 | $14,607,000 | -59.1% | 900,000 | -10.0% | 0.47% | -66.9% |
| Q4 2017 | $35,750,000 | +309.9% | 1,000,000 | +289.9% | 1.41% | +300.9% |
| Q2 2014 | $8,721,000 | +137.2% | 256,500 | +119.8% | 0.35% | +134.0% |
| Q1 2014 | $3,676,000 | – | 116,689 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |